Stock Chart
ALMS
Type: SELL wallstreet
Strike: $40
Premium: $7.87
Expiry: Dec 18, 2026
Target: $37
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About ALMS - Alumis Inc. Common Stock
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
Key Statistics
More ALMS Analysis
This ALMS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ALMS's price movements with trendlines, gamma walls, and key support/resistance levels.